Anzeige
Mehr »
Lynx Broker
Login
Mittwoch, 11.12.2019 Börsentäglich über 12.000 News von 620 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12B8E ISIN: IE00BQPVQZ61 Ticker-Symbol: HPR 
Tradegate
10.12.19
19:05 Uhr
29,000 Euro
+0,200
+0,69 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
HORIZON THERAPEUTICS PLC Chart 1 Jahr
5-Tage-Chart
HORIZON THERAPEUTICS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
28,800
29,000
14:25
28,800
29,000
10:16

Aktuelle News zur HORIZON THERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoHorizon Therapeutics plc to Present at the 38th Annual J.P. Morgan Healthcare Conference121Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the 38th Annual J.P. Morgan Healthcare Conference. Timothy Walbert, chairman, president and chief executive...
► Artikel lesen
26.11.Horizon Therapeutics Expands Capabilities3
Börsennews zur HORIZON THERAPEUTICS Aktie und weiteren Hot Stocks erhalten
22.11.Horizon Therapeutics opens new facility in South San Francisco2
21.11.Horizon Therapeutics plc Launches New Online Community Connecting People Living with Thyroid Eye Disease and Urging them to "Listen to Your Eyes"182Horizon Therapeutics plc (Nasdaq: HZNP) today announced the launch of "Listen to Your Eyes," a new website and Facebook community designed to provide education and support for people who are living...
► Artikel lesen
14.11.FORTUNE and Great Place to Work Name Horizon Therapeutics plc to Best Workplaces for Parents List1.535Horizon Therapeutics plc (NASDAQ: HZNP) announced today that it has been named to FORTUNE Magazine's 2019 "Best Workplaces for Parents" list, which highlights companies that best support employees...
► Artikel lesen
13.11.Horizon Therapeutics plc to Participate in Upcoming Investor Conferences176Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming conferences: Stifel 2019 Healthcare Conference Date: Tuesday, Nov....
► Artikel lesen
13.11.Horizon Therapeutics Public Limited Company 2019 Q3 - Results - Earnings Call Presentation1
08.11.The Chicago Tribune Names Horizon Therapeutics plc a 2019 Top Workplace261Horizon Therapeutics plc (Nasdaq: HZNP) has been awarded a Top Workplaces 2019 honor by the Chicago Tribune. This is the fifth consecutive year Horizon has received this honor. "We take tremendous...
► Artikel lesen
08.11.Horizon Therapeutics' (HZNP) Q3 Earnings Beat Estimates4
06.11.Horizon Therapeutics Public Ltd Co - 10-Q, Quaterly Report2
06.11.Horizon Therapeutics Public Ltd Co - 8-K, Current Report1
24.10.Exagen, Inc.: AVISE MTX Test from Exagen Supports Horizon Therapeutics plc Clinical Trial to Evaluate Pegloticase ...1
18.10.Horizon Therapeutics initiates PROTECT clinical trial of KRYSTEXXA (pegloticase injection)1
17.10.FORTUNE and Great Place to Work Name Horizon Therapeutics plc to Best Small & Medium Workplaces List for Fourth Consecutive Year166Horizon Therapeutics plc (NASDAQ: HZNP) announced today that it has been selected to FORTUNE Magazine's 2019 "Best Medium Workplaces" list for the fourth consecutive year. Horizon ranked eighth out...
► Artikel lesen
17.10.Horizon Therapeutics launches PROTECT trial evaluating KRYSTEXXA in uncontrolled gout2
17.10.Horizon Therapeutics plc Initiates PROTECT Trial Evaluating KRYSTEXXA (pegloticase injection) to Improve Management of Uncontrolled Gout for Adults with a Kidney Transplant139-- Trial to evaluate the effectiveness of KRYSTEXXA to sustain reduced serum uric acid levels for post-kidney transplant adults; a vulnerable population -- Horizon Therapeutics plc (Nasdaq: HZNP)...
► Artikel lesen
11.10.Horizon Therapeutics' Phase 3 trial finds 'significant benefit' of teprotumumab2
09.10.Horizon Therapeutics plc to Release Third-Quarter 2019 Financial Results and Host Webcast on Nov. 6, 2019197Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its third-quarter 2019 financial results will be released on Wednesday, Nov. 6, 2019. Following the announcement, Horizon's management...
► Artikel lesen
09.10.Horizon Therapeutics to move global HQ to 70 St Stephen's Green1
03.10.Horizon Therapeutics plc Named One of the Best Adoption-Friendly Workplaces by the Dave Thomas Foundation for Adoption215Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named one of the top 100 adoption-friendly workplaces in the country by the Dave Thomas Foundation for Adoption, ranking number...
► Artikel lesen
Seite:  Weiter >>
72 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1